109 related articles for article (PubMed ID: 23751561)
41. Gene transfer of the urokinase-type plasminogen activator receptor-targeted matrix metalloproteinase inhibitor TIMP-1.ATF suppresses neointima formation more efficiently than tissue inhibitor of metalloproteinase-1.
Lamfers ML; Grimbergen JM; Aalders MC; Havenga MJ; de Vries MR; Huisman LG; van Hinsbergh VW; Quax PH
Circ Res; 2002 Nov; 91(10):945-52. PubMed ID: 12433840
[TBL] [Abstract][Full Text] [Related]
42. Urokinase receptor antagonists inhibit angiogenesis and primary tumor growth in syngeneic mice.
Min HY; Doyle LV; Vitt CR; Zandonella CL; Stratton-Thomas JR; Shuman MA; Rosenberg S
Cancer Res; 1996 May; 56(10):2428-33. PubMed ID: 8625323
[TBL] [Abstract][Full Text] [Related]
43. Anti-angiogenic quassinoid-rich fraction from Eurycoma longifolia modulates endothelial cell function.
Al-Salahi OS; Kit-Lam C; Majid AM; Al-Suede FS; Mohammed Saghir SA; Abdullah WZ; Ahamed MB; Yusoff NM
Microvasc Res; 2013 Nov; 90():30-9. PubMed ID: 23899415
[TBL] [Abstract][Full Text] [Related]
44. Expression and functional characterization of a recombinant targeted toxin with an uPA cleavable linker in Pichia pastoris.
Zhu Wh; Sun Mn; Wang Ys; Sun DJ; Zhang Sx
Protein Expr Purif; 2011 Apr; 76(2):184-9. PubMed ID: 21144903
[TBL] [Abstract][Full Text] [Related]
45. Comparison of the purification of biologically active IL-7 cytokine expressed in Escherichia coli and Pichia pastoris.
Zaremba-Czogalla M; Stumpp C; Bonifacio E; Paul R
Protein Expr Purif; 2015 Jun; 110():65-71. PubMed ID: 25703052
[TBL] [Abstract][Full Text] [Related]
46. Expression of antisense uPAR and antisense uPA from a bicistronic adenoviral construct inhibits glioma cell invasion, tumor growth, and angiogenesis.
Gondi CS; Lakka SS; Yanamandra N; Siddique K; Dinh DH; Olivero WC; Gujrati M; Rao JS
Oncogene; 2003 Sep; 22(38):5967-75. PubMed ID: 12955075
[TBL] [Abstract][Full Text] [Related]
47. Urokinase-type plasminogen activator expression correlates with tumor angiogenesis and poor outcome in gastric cancer.
Kaneko T; Konno H; Baba M; Tanaka T; Nakamura S
Cancer Sci; 2003 Jan; 94(1):43-9. PubMed ID: 12708473
[TBL] [Abstract][Full Text] [Related]
48. Suppression of the uPAR-uPA system retards angiogenesis, invasion, and in vivo tumor development in pancreatic cancer cells.
Gorantla B; Asuthkar S; Rao JS; Patel J; Gondi CS
Mol Cancer Res; 2011 Apr; 9(4):377-89. PubMed ID: 21389187
[TBL] [Abstract][Full Text] [Related]
49. Pichia pastoris as a host for secretion of toxic saporin chimeras.
Lombardi A; Bursomanno S; Lopardo T; Traini R; Colombatti M; Ippoliti R; Flavell DJ; Flavell SU; Ceriotti A; Fabbrini MS
FASEB J; 2010 Jan; 24(1):253-65. PubMed ID: 19786581
[TBL] [Abstract][Full Text] [Related]
50. Melanoma cell migration on vitronectin: regulation by components of the plasminogen activation system.
Stahl A; Mueller BM
Int J Cancer; 1997 Mar; 71(1):116-22. PubMed ID: 9096674
[TBL] [Abstract][Full Text] [Related]
51. Intracellular expression and purification of the Canstatin-N protein in Pichia pastoris.
Yin H; Liu Z; Zhang A; Zhang T; Luo J; Shen J; Chen L; Zhou B; Fu X; Fu C; Zhang Z
Gene; 2012 Aug; 504(1):122-6. PubMed ID: 22575729
[TBL] [Abstract][Full Text] [Related]
52. Downregulation of uPA/uPAR inhibits intermittent hypoxia-induced epithelial-mesenchymal transition (EMT) in DAOY and D283 medulloblastoma cells.
Gupta R; Chetty C; Bhoopathi P; Lakka S; Mohanam S; Rao JS; Dinh DE
Int J Oncol; 2011 Mar; 38(3):733-44. PubMed ID: 21181094
[TBL] [Abstract][Full Text] [Related]
53. [Molecular cloning and expression of the cDNA encoding angiogenesis inhibitor K4K5 with Pichia pastoris].
Guan XQ; Wang YX; Wu LC; Song HY
Sheng Wu Gong Cheng Xue Bao; 2001 Mar; 17(2):126-30. PubMed ID: 11411216
[TBL] [Abstract][Full Text] [Related]
54. High level expression of kringle 5 fragment of plasminogen in Pichia pastoris.
Zhou Y; Zheng Q; Gao J; Gu J
Biotechnol Lett; 2005 Feb; 27(3):167-71. PubMed ID: 15717125
[TBL] [Abstract][Full Text] [Related]
55. Urokinase receptor in human malignant mesothelioma cells: role in tumor cell mitogenesis and proteolysis.
Shetty S; Kumar A; Johnson A; Pueblitz S; Idell S
Am J Physiol; 1995 Jun; 268(6 Pt 1):L972-82. PubMed ID: 7611439
[TBL] [Abstract][Full Text] [Related]
56. High-affinity urokinase-derived cyclic peptides inhibiting urokinase/urokinase receptor-interaction: effects on tumor growth and spread.
Sato S; Kopitz C; Schmalix WA; Muehlenweg B; Kessler H; Schmitt M; Krüger A; Magdolen V
FEBS Lett; 2002 Sep; 528(1-3):212-6. PubMed ID: 12297307
[TBL] [Abstract][Full Text] [Related]
57. Crystallization of soluble urokinase receptor (suPAR) in complex with urokinase amino-terminal fragment (1-143).
Huang M; Mazar AP; Parry G; Higazi AA; Kuo A; Cines DB
Acta Crystallogr D Biol Crystallogr; 2005 Jun; 61(Pt 6):697-700. PubMed ID: 15930623
[TBL] [Abstract][Full Text] [Related]
58. Proteolytically inactive recombinant forms of urokinase suppress migration of endothelial cells.
Beloglazova IB; Zubkova ES; Stambol'skii DV; Plekhanova OS; Men'shikov MY; Akopyan ZhA; Bibilashvili RSh; Parfenova EV; Tkachuk VA
Bull Exp Biol Med; 2014 Apr; 156(6):756-9. PubMed ID: 24824689
[TBL] [Abstract][Full Text] [Related]
59. RNA interference-mediated targeting of urokinase plasminogen activator receptor and matrix metalloproteinase-9 gene expression in the IOMM-lee malignant meningioma cell line inhibits tumor growth, tumor cell invasion and angiogenesis.
Tummalapalli P; Gondi CS; Dinh DH; Gujrati M; Rao JS
Int J Oncol; 2007 Jul; 31(1):5-17. PubMed ID: 17549400
[TBL] [Abstract][Full Text] [Related]
60. SPARC-induced migration of glioblastoma cell lines via uPA-uPAR signaling and activation of small GTPase RhoA.
Kunigal S; Gondi CS; Gujrati M; Lakka SS; Dinh DH; Olivero WC; Rao JS
Int J Oncol; 2006 Dec; 29(6):1349-57. PubMed ID: 17088972
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
